RxDoctor Payments Data

Wilhelmina Prinssen, MD

Family Medicine · Atlanta, GANPI 1477870111

Payments from drug & device makers

$915in general payments, 2019–2025

Across 52 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$402
  • GSK$330
  • Johnson & Johnson$47
  • Gilead$40
  • Novartis$38
  • Dynavax Technologies Corporation$17
  • plus $40 from 3 others

What the payments were for

  • Food & beverage$915100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$915 in reported general payments places this provider in the 55th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$10,230
Medicare patients
48
Services billed
117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide126$151,658
FarxigaDapagliflozin Propanediol47$70,462
EliquisApixaban69$59,554
JanuviaSitagliptin Phosphate24$38,577
JardianceEmpagliflozin30$37,287
TrulicityDulaglutide18$28,099
Tresiba Flextouch U-100Insulin Degludec25$18,006
Spiriva RespimatTiotropium Bromide23$17,149
Atrovent HfaIpratropium Bromide29$12,753
MyrbetriqMirabegron12$11,702
Incruse ElliptaUmeclidinium Bromide11$7,189
Fluticasone-SalmeterolFluticasone Propion/Salmeterol32$6,631
Esomeprazole Magnesium62$6,286
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$6,126
Albuterol Sulfate HfaAlbuterol Sulfate168$5,984

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Levemir$12$154,159137 claims
PfizerEliquis$402$59,55469 claims
MerckJanuvia$15$38,57724 claims
GSKIncruse Ellipta, Arnuity Ellipta$330$9,37122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →